XESX:LSE:LSE-Xtrackers Euro Stoxx 50 UCITS ETF 1D (GBX)

ETF | Others |

Last Closing

USD 4104.5

Change

-32.50 (-0.79)%

Market Cap

N/A

Volume

8.11K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+1.99 (+0.74%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

+0.50 (+0.25%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+3.43 (+2.45%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.05 (-0.36%)

USD 584.80B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.02 (-0.10%)

USD 583.82B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
0QZO:LSE 0QZO

-1.60 (-1.41%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

N/A

USD 218.91B
0QZ3:LSE Qualcomm Inc.

+2.06 (+1.27%)

USD 202.26B

ETFs Containing XESX:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.43% 28% F 40% F
Dividend Return -0.07% 5% F 2% F
Total Return 0.36% 26% F 38% F
Trailing 12 Months  
Capital Gain 4.67% 32% F 41% F
Dividend Return -0.07% 4% F 2% F
Total Return 4.59% 30% F 39% F
Trailing 5 Years  
Capital Gain 21.71% 48% F 57% F
Dividend Return -0.03% 6% D- 5% F
Total Return 21.69% 46% F 56% F
Average Annual (5 Year Horizon)  
Capital Gain 9.53% 62% D 66% D+
Dividend Return 9.54% 62% D 66% D+
Total Return 0.02% 27% F 47% F
Risk Return Profile  
Volatility (Standard Deviation) 13.70% 52% F 69% C-
Risk Adjusted Return 69.63% 73% C 84% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.